LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article: COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey.

    Sabatino, Jolanda / Ferrero, Paolo / Chessa, Massimo / Bianco, Francesco / Ciliberti, Paolo / Secinaro, Aurelio / Oreto, Lilia / Avesani, Martina / Bucciarelli, Valentina / Calcaterra, Giuseppe / Calabrò, Maria Pia / Russo, Maria Giovanna / Bassareo, Pier Paolo / Guccione, Paolo / Indolfi, Ciro / Di Salvo, Giovanni

    Journal of clinical medicine

    2020  Volume 9, Issue 6

    Abstract: ... characteristics and outcomes in patients with congenital heart disease affected by COVID-19.: Methods and ... results: This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD ... Background: The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging ...

    Abstract Background: The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number of hospitalized patients. Cardiovascular co-morbidities are linked to a higher mortality risk. Thus, patients with Congenital Heart Disease (CHD) might represent a high-risk population. Nevertheless, no data about them are available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes in patients with congenital heart disease affected by COVID-19.
    Methods and results: This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD centres. COVID-19 diagnosis was defined as either "clinically suspected" or "confirmed", where a severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) test had been performed and was positive. Cardiovascular comorbidities were observed among adult patients-atrial fibrillation (seven; 9%), hypertension (five; 7%), obesity (seven; 9%) and diabetes (one; 1%)-but were absent among children. Cardiovascular complications were mainly observed in the "confirmed" COVID-19
    Conclusions: Despite previous reports pointing to a higher case-fatality rate among patients with cardiovascular co-morbidities, we observed a mild COVID-19 clinical course in our cohort of CHD patients. Although these results should be confirmed in larger cohorts to investigate the underlying mechanisms, the findings of low cardiovascular complications rates and no deaths are reassuring for CHD patients.
    Keywords covid19
    Language English
    Publishing date 2020-06-08
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm9061774
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: COVID-19 and congenital heart disease: Results from a nationwide survey

    Sabatino, Jolanda / Ferrero, Paolo / Chessa, Massimo / Bianco, Francesco / Ciliberti, Paolo / Secinaro, Aurelio / Oreto, Lilia / Avesani, Martina / Bucciarelli, Valentina / Calcaterra, Giuseppe / Calabrò, Maria Pia / Russo, Maria Giovanna / Bassareo, Pier Paolo / Guccione, Paolo / Indolfi, Ciro / Di Salvo, Giovanni

    J. Clin. Med.

    Abstract: ... characteristics and outcomes in patients with congenital heart disease affected by COVID-19. Methods and Results ... This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD centres. COVID ... Background. The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging ...

    Abstract Background. The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number of hospitalized patients. Cardiovascular co-morbidities are linked to a higher mortality risk. Thus, patients with Congenital Heart Disease (CHD) might represent a high-risk population. Nevertheless, no data about them are available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes in patients with congenital heart disease affected by COVID-19. Methods and Results. This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD centres. COVID-19 diagnosis was defined as either “clinically suspected” or “confirmed”, where a severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) test had been performed and was positive. Cardiovascular comorbidities were observed among adult patients—atrial fibrillation (seven; 9%), hypertension (five; 7%), obesity (seven; 9%) and diabetes (one; 1%)—but were absent among children. Cardiovascular complications were mainly observed in the “confirmed” COVID-19+group, consisting of heart failure (9%), palpitations/arrhythmias (3%), stroke/TIA (3%) and pulmonary hypertension (3%). Cardiovascular symptoms such as chest pain (1%), myocardial injury (1%) and pericardial effusion (1%) were also recorded. On the contrary, CHD patients from the clinically suspected COVID-19 group presented no severe symptoms or complications. Conclusions. Despite previous reports pointing to a higher case-fatality rate among patients with cardiovascular co-morbidities, we observed a mild COVID-19 clinical course in our cohort of CHD patients. Although these results should be confirmed in larger cohorts to investigate the underlying mechanisms, the findings of low cardiovascular complications rates and no deaths are reassuring for CHD patients.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #574843
    Database COVID19

    Kategorien

  3. Article ; Online: COVID-19 and Congenital Heart Disease

    Sabatino, Jolanda / Ferrero, Paolo / Chessa, Massimo / Bianco, Francesco / Ciliberti, Paolo / Secinaro, Aurelio / Oreto, Lilia / Avesani, Martina / Bucciarelli, Valentina / Calcaterra, Giuseppe / Pia Calabrò, Maria / Giovanna Russo, Maria / Paolo Bassareo, Pier / Guccione, Paolo / Indolfi, Ciro / Di Salvo, Giovanni

    Results from a Nationwide Survey

    2020  

    Abstract: ... in patients with congenital heart disease affected by COVID-19. ... available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes ... The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number ...

    Abstract The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number of hospitalized patients. Cardiovascular co-morbidities are linked to a higher mortality risk. Thus, patients with Congenital Heart Disease (CHD) might represent a high-risk population. Nevertheless, no data about them are available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes in patients with congenital heart disease affected by COVID-19.
    Keywords COVID-19 ; cardiovascular complications ; congenital heart disease ; covid19
    Language English
    Publishing country it
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Covid-19 and Congenital Heart Disease

    Sabatino, Jolanda / Ferrero, Paolo / Chessa, Massimo / Bianco, Francesco / Ciliberti, Paolo / Secinaro, Aurelio / Oreto, Lilia / Avesani, Martina / Bucciarelli, Valentina / Calcaterra, Giuseppe / Calabro', Maria Pia / Giovanna Russo, Maria / Paolo Bassareo, Pier / Guccione, Paolo / Indolfi, Ciro / Salvo., and Giovanni Di

    results from a nationwide survey

    2020  

    Keywords covid19
    Language English
    Publishing country it
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: COVID-19 and Congenital Heart Disease

    Jolanda Sabatino / Paolo Ferrero / Massimo Chessa / Francesco Bianco / Paolo Ciliberti / Aurelio Secinaro / Lilia Oreto / Martina Avesani / Valentina Bucciarelli / Giuseppe Calcaterra / Maria Pia Calabrò / Maria Giovanna Russo / Pier Paolo Bassareo / Paolo Guccione / Ciro Indolfi / Giovanni Di Salvo

    Journal of Clinical Medicine, Vol 9, Iss 1774, p

    Results from a Nationwide Survey

    2020  Volume 1774

    Abstract: ... characteristics and outcomes in patients with congenital heart disease affected by COVID-19. Methods and Results ... This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD centres. COVID ... mainly observed in the “confirmed” COVID-19 + group, consisting of heart failure (9%), palpitations ...

    Abstract Background. The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number of hospitalized patients. Cardiovascular co-morbidities are linked to a higher mortality risk. Thus, patients with Congenital Heart Disease (CHD) might represent a high-risk population. Nevertheless, no data about them are available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes in patients with congenital heart disease affected by COVID-19. Methods and Results. This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD centres. COVID-19 diagnosis was defined as either “clinically suspected” or “confirmed”, where a severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) test had been performed and was positive. Cardiovascular comorbidities were observed among adult patients—atrial fibrillation (seven; 9%), hypertension (five; 7%), obesity (seven; 9%) and diabetes (one; 1%)—but were absent among children. Cardiovascular complications were mainly observed in the “confirmed” COVID-19 + group, consisting of heart failure (9%), palpitations/arrhythmias (3%), stroke/TIA (3%) and pulmonary hypertension (3%). Cardiovascular symptoms such as chest pain (1%), myocardial injury (1%) and pericardial effusion (1%) were also recorded. On the contrary, CHD patients from the clinically suspected COVID-19 group presented no severe symptoms or complications. Conclusions. Despite previous reports pointing to a higher case-fatality rate among patients with cardiovascular co-morbidities, we observed a mild COVID-19 clinical course in our cohort of CHD patients. Although these results should be confirmed in larger cohorts to investigate the underlying mechanisms, the findings of low cardiovascular complications rates and no deaths are reassuring for CHD patients.
    Keywords congenital heart disease ; COVID-19 ; cardiovascular complications ; Medicine ; R ; covid19
    Subject code 610 ; 616
    Language English
    Publishing date 2020-06-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Book ; Online: COVID-19 and Congenital Heart Disease

    Jolanda Sabatino / Paolo Ferrero / Massimo Chessa / Francesco Bianco / Paolo Ciliberti / Aurelio Secinaro / Lilia Oreto / Martina Avesani / Valentina Bucciarelli / Giuseppe Calcaterra / Maria Pia Calabrò / Maria Giovanna Russo / Pier Paolo Bassareo / Paolo Guccione / Ciro Indolfi / Giovanni Di Salvo

    Journal of Clinical Medicine ; Volume 9 ; Issue 6

    Results from a Nationwide Survey

    2020  

    Abstract: ... characteristics and outcomes in patients with congenital heart disease affected by COVID-19. Methods and Results ... This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD centres. COVID ... Background. The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging ...

    Abstract Background. The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number of hospitalized patients. Cardiovascular co-morbidities are linked to a higher mortality risk. Thus, patients with Congenital Heart Disease (CHD) might represent a high-risk population. Nevertheless, no data about them are available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes in patients with congenital heart disease affected by COVID-19. Methods and Results. This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD centres. COVID-19 diagnosis was defined as either “

    clinically suspected”

    or “

    confirmed”

    where a severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) test had been performed and was positive. Cardiovascular comorbidities were observed among adult patients—

    atrial fibrillation (seven

    9%), hypertension (five

    7%), obesity (seven

    9%) and diabetes (one

    1%)—

    but were absent among children. Cardiovascular complications were mainly observed in the “

    confirmed”

    COVID-19+ group, consisting of heart failure (9%), palpitations/arrhythmias (3%), stroke/TIA (3%) and pulmonary hypertension (3%). Cardiovascular symptoms such as chest pain (1%), myocardial injury (1%) and pericardial effusion (1%) were also recorded. On the contrary, CHD patients from the clinically suspected COVID-19 group presented no severe symptoms or complications. Conclusions. Despite previous reports pointing to a higher case-fatality rate among patients with cardiovascular co-morbidities, we observed a mild COVID-19 clinical course in our cohort of CHD patients. Although these results should be confirmed in larger cohorts to investigate the underlying mechanisms, the findings of low cardiovascular complications rates and no deaths are reassuring for CHD patients.
    Keywords congenital heart disease ; COVID-19 ; cardiovascular complications ; covid19
    Subject code 610 ; 616
    Language English
    Publishing date 2020-06-08
    Publisher Multidisciplinary Digital Publishing Institute
    Publishing country ch
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: Congenital heart surgery in Spain during the state of alarm related to COVID-19/ Cirugía de cardiopatías congénitas en España durante el estado de alarma por COVID-19

    Polo López, Luz / Centella Hernández, Tomasa / González Calle, Antonio / Bautista Hernández, Víctor / Gil Jaúrena, Juan Miguel / Fernández Doblas, Joaquín / Aramendi Gallardo, José Ignacio / Ríos Rodríguez, Luis / Ruiz Alonso, Enrique / Boni, Lorenzo / Merino Cejas, Carlos / Aguilar Jiménez, Juan Miguel / Serrano Martínez, Félix / Caffarena Calvar, José María

    Cir. Cardiovasc.

    Abstract: ... pandemic. Although clinical involvement of children and patients with congenital heart disease are not ... to return to normal. Methods: From our Society congenital heart disease working group, a survey was carried ... the reduction of our congenital heart surgery over these 2 months of state of alarm, and we propose strategies ...

    Abstract Introduction-objectives: We live in exceptional times caused by the new SARS-CoV-2 coronavirus pandemic. Although clinical involvement of children and patients with congenital heart disease are not frequent, the emergency care of adults with COVID-19 has almost collapsed our healthcare system. Consequently, the whole standard activity has been minimized during this period. In this manuscript we analyse the reduction of our congenital heart surgery over these 2 months of state of alarm, and we propose strategies to return to normal. Methods: From our Society congenital heart disease working group, a survey was carried out in Spanish congenital heart disease surgery hospitals, in order to find out the decrease in activity caused by the COVID-19 pandemic during the time period from March-13 to May-13, 2020. Results: During the pandemic, congenital heart disease surgery was partially reduced, stepping with the most urgent cases and minimizing the scheduled activity. Compared to the same period in 2019, 51% less major surgery and 54% less extracorporeal surgery were performed. Collaboration in adults COVID-19 front line care has been 15%, having 7% of our specialists on quarantine. Before operating on any patient, the PCR is asked to rule out SARS-CoV-2 infection and, if positive, we only consider intervention in urgent / emergency cases. Conclusions: The SARS-CoV-2 pandemic has forced all the congenital heart disease services nationwide to restructure, aiming to support colleagues with direct treatment of COVID-19, without sacrificing the healthcare of our own patients whose surgery could not be delayed.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #622447
    Database COVID19

    Kategorien

To top